National Institutes of Health NIDDK/DKUHD. Excerpts from the United States Renal Data System’s 2002 Annual Report. Am J Kidney Dis. 2003;41:S71-S80.
2.
II. NKF-K/DOQI Clinical practice guidelines for peritoneal dialysis adequacy: update 2000. Am J Kidney Dis. 2001;37:S65-S136.
3.
I. NKF-K/DOQI Clinical practice guidelines for hemodialysis adequacy: update 2000. Am J Kidney Dis. 2001;37:S7-S64.
4.
Warady BA, Schaefer F, Alexander SR, et al.Care of the Pediatric Patient on Peritoneal Dialysis. Clinical Process for Optimal Outcomes. Deerfield, IL: Baxter Healthcare; 2004.
5.
III.NKF-K/DOQI Clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis. 2001;37:S137-S181.
6.
Warady BA, Alexander SR, Hossli S, et al.Peritoneal membrane transport function in children receiving long-term dialysis. J Am Soc Nephrol. 1996;7:2385-2391.
7.
Tzamaloukas A, Fox L. Infections in patients on peritoneal dialysis. In: Henrich WL, ed. Principles and Practice of Dialysis. Philadelphia: Lippincott Williams and Wilkins; 2004:629-647.
8.
Warady BA, Schaefer F, Holloway M, et al.Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int. 2000;20:610-624.
9.
Bunchman TE, Maxvold NJ, Brophy PD. Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis. 2003;42:1248-1252.
10.
Chadha V, Garg U, Warady BA, Alon US. Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol. 2002;17:819-824.